Skip to main content
FinSpry Logo
FinSpry
MRSN logo
MRSN
(NASDAQ)
Mersana Therapeutics, Inc.
$29.08-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Mersana Therapeutics (MRSN) Stock Price & Financial Analysis

Mersana Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$29.08 - $29.08
52-Week High$30.39
52-Week Low$5.21
Open$29.08
Market Cap145.19M
Shares Outstanding4.99M
Price to Sales (P/S)4.38
EV/EBITDA-1.34
Revenue (TTM)33.18M
Net Income (TTM)-70.08M
Free Cash Flow (TTM)-74.50M
EPS (TTM)$-14.04
Profit Margin-211.21%
Operating Margin-203.06%
50-Day MA$22.88
200-Day MA$11.99
52-Week Change-16.32%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Mersana Therapeutics

What is the current stock price for MRSN?

As of the latest trading session, MRSN stock trades at $29.08. The 52-week range is $5.21–$30.39, with a day range of $29.08–$29.08.

What is the P/E ratio for MRSN?

The P/E ratio (Price-to-Earnings) for MRSN is shown in the Key Statistics section. This valuation metric helps compare Mersana Therapeutics, Inc. to industry peers.

Does MRSN pay dividends?

Mersana Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for MRSN?

Analyst ratings and recommendations for MRSN are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of MRSN?

Mersana Therapeutics's market capitalization is $145.2M, classifying it as a micro-cap company. Mersana Therapeutics operates in the Healthcare sector within the Biotechnology industry.